RxDoctor Payments Data

Milana Matz

Optometrist · Northbrook, ILNPI 1609251297

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Alcon accounts for 97.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $44,228 and has fallen 99.5% since, to $225 in 2025. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,392in general payments, 2019–2025

Across 161 payments — averaging $344.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$54K
  • Novartis$153
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$135
  • Dompe US, Inc.$120
  • Amgen$119
  • Tarsus Pharmaceuticals, Inc.$118
  • plus $505 from 10 others

What the payments were for

  • Consulting fees$31,46557%
  • Speaking & faculty fees$2,2804%
  • Travel & lodging$18,94234%
  • Food & beverage$2,7055%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,392 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$143,048
Medicare patients
553
Services billed
2,195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Brimonidine Tartrate39$1,743
TafluprostTafluprost/Pf14$1,531
Latanoprost134$1,123
Prednisolone Acetate16$620
Timolol Maleate52$511
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha34$351
Doxycycline Hyclate12$206
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat26$178
Ofloxacin21$143
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$60

Paid to pharmacies, not to this prescriber.

Other optometrist in Northbrook

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →